- 专利标题： Heterocyclic inhibitors of ATR kinase
-
申请号： US16104561申请日： 2018-08-17
-
公开(公告)号： US10800774B2公开(公告)日： 2020-10-13
- 发明人: Maria Emilia Di Francesco , Philip Jones , Christopher Lawrence Carroll , Jason Bryant Cross , Zhijun Kang , Michael Garrett Johnson , Sarah Lively
- 申请人： Board of Regents, The University of Texas System , ChemPartner Corporation
- 申请人地址： US TX Austin US CA South San Francisco
- 专利权人： Board of Regents, The University of Texas System,ChemPartner Corporation
- 当前专利权人： Board of Regents, The University of Texas System,ChemPartner Corporation
- 当前专利权人地址： US TX Austin US CA South San Francisco
- 代理商 Dennis A. Bennett; Cynthia Hathaway; John Desper
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; C07D413/14 ; A61P35/00
摘要：
The present invention relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.
公开/授权文献
- US20190055240A1 HETEROCYCLIC INHIBITORS OF ATR KINASE 公开/授权日：2019-02-21
信息查询
